Skip Nav Destination
A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481
Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial
Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy
Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Splenic marginal zone lymphoma: a prognostic model for clinical use
Eradication of minimal residual disease in hairy cell leukemia
Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone: results from the Japan Infant Leukemia Study Group
Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24 000 years ago
False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise
Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression
Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia
Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research
Issue Archive
June 15 2006
Table of Contents
INSIDE BLOOD
PERSPECTIVES
REVIEW IN TRANSLATIONAL HEMATOLOGY
CHEMOKINES, CYTOKINES, AND INTERLEUKINS
CLINICAL TRIALS AND OBSERVATIONS
A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481
Clinical Trials & Observations
Gita V. Massey,Alvin Zipursky,Myron N. Chang,John J. Doyle,Suhail Nasim,Jeffrey W. Taub,Yaddanapudi Ravindranath,Gary Dahl,Howard J. Weinstein
Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial
Clinical Trials & Observations
Donald W. Milligan,Keith Wheatley,Timothy Littlewood,Jenny I. O. Craig,Alan K. Burnett,for the NCRI Haematological Oncology Clinical Studies Group
Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma
Clinical Trials & Observations
Douglas A. Stewart,Nizar Bahlis,Karen Valentine,Alex Balogh,Lynn Savoie,Donald G. Morris,Allan Jones,Chris Brown,James A. Russell
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy
Clinical Trials & Observations
Philip S. Rosenberg,Blanche P. Alter,Audrey A. Bolyard,Mary Ann Bonilla,Laurence A. Boxer,Bonnie Cham,Carol Fier,Melvin Freedman,George Kannourakis,Sally Kinsey,Beate Schwinzer,Connie Zeidler,Karl Welte,David C. Dale,for the Severe Chronic Neutropenia International Registry
Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Clinical Trials & Observations
Christophe Fermé,Nicolas Mounier,Olivier Casasnovas,Pauline Brice,Marine Divine,Anne Sonet,Fahdela Bouafia,Aspasia Bastard-Stamatoullas,Dominique Bordessoule,Laurent Voillat,Oumedaly Reman,Michel Blanc,Christian Gisselbrecht,for the Groupe d'Etude des Lymphomes de l'Adulte
Splenic marginal zone lymphoma: a prognostic model for clinical use
Clinical Trials & Observations
Luca Arcaini,Mario Lazzarino,Nora Colombo,Sara Burcheri,Emanuela Boveri,Marco Paulli,Enrica Morra,Marcello Gambacorta,Sergio Cortelazzo,Alessandra Tucci,Marco Ungari,Achille Ambrosetti,Fabio Menestrina,Lorella Orsucci,Domenico Novero,Alessandro Pulsoni,Maurizio Frezzato,Gianluca Gaidano,Daniele Vallisa,Viviana Minardi,Claudio Tripodo,Vincenzo Callea,Luca Baldini,Francesco Merli,Massimo Federico,Vito Franco,Emilio Iannitto,for the Intergruppo Italiano Linfomi
Eradication of minimal residual disease in hairy cell leukemia
Clinical Trials & Observations
Farhad Ravandi,Jeffrey L. Jorgensen,Susan M. O'Brien,Srdan Verstovsek,Charles A. Koller,Stefan Faderl,Francis J. Giles,Alessandra Ferrajoli,William G. Wierda,Shirley Odinga,Xuelin Huang,Deborah A. Thomas,Emil J. Freireich,Dan Jones,Michael J. Keating,Hagop M. Kantarjian
Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone: results from the Japan Infant Leukemia Study Group
Clinical Trials & Observations
Jun Nagayama,Daisuke Tomizawa,Katsuyoshi Koh,Yoshihisa Nagatoshi,Noriko Hotta,Tomoko Kishimoto,Yoshihiro Takahashi,Tomoko Kuno,Kanji Sugita,Takashi Sato,Kohji Kato,Atsushi Ogawa,Tatsutoshi Nakahata,Shuki Mizutani,Keizo Horibe,Eiichi Ishii
Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24 000 years ago
Clinical Trials & Observations
Ariella Zivelin,Ronit Mor-Cohen,Victoria Kovalsky,Nurit Kornbrot,Jacqueline Conard,Flora Peyvandi,Paul A. Kyrle,Rogier Bertina,Ferial Peyvandi,Joseph Emmerich,Uri Seligsohn
GENE THERAPY
HEMATOPOIESIS
The SCL relative LYL-1 is required for fetal and adult hematopoietic stem cell function and B-cell differentiation
Claude Capron,Yann Lécluse,Anna Lila Kaushik,Adlen Foudi,Catherine Lacout,Dalila Sekkai,Isabelle Godin,Olivier Albagli,Isabelle Poullion,Fedor Svinartchouk,Elisabeth Schanze,William Vainchenker,Fred Sablitzky,Annelise Bennaceur-Griscelli,Dominique Duménil
Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells
Richard D. Unwin,Duncan L. Smith,David Blinco,Claire L. Wilson,Crispin J. Miller,Caroline A. Evans,Ewa Jaworska,Stephen A. Baldwin,Kay Barnes,Andrew Pierce,Elaine Spooncer,Anthony D. Whetton
False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise
Clinical Trials & Observations
Brief Report
RETRACTIONS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression
Clinical Trials & Observations
Claudia Pastori,Barbara Weiser,Claudia Barassi,Caterina Uberti-Foppa,Silvia Ghezzi,Renato Longhi,Giliola Calori,Harold Burger,Kimdar Kemal,Guido Poli,Adriano Lazzarin,Lucia Lopalco
Innate immunity defects in Hermansky-Pudlak type 2 syndrome
Stefania Fontana,Silvia Parolini,William Vermi,Sarah Booth,Federico Gallo,Marta Donini,Marzia Benassi,Francesca Gentili,Daniela Ferrari,Lucia D. Notarangelo,Patrizia Cavadini,Emanuela Marcenaro,Stefano Dusi,Marco Cassatella,Fabio Facchetti,Gillian M. Griffiths,Alessandro Moretta,Luigi D. Notarangelo,Raffaele Badolato
Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections
Clinical Trials & Observations
Tom Sprong,Dirk Roos,Corry Weemaes,Chris Neeleman,Christel L. M. Geesing,Tom Eirik Mollnes,Marcel van Deuren
NEOPLASIA
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia
Clinical Trials & Observations
Mariano Monzo,Salut Brunet,Alvaro Urbano-Ispizua,Alfons Navarro,Granada Perea,Jordi Esteve,Rosa Artells,Miquel Granell,Juan Berlanga,Josep M. Ribera,Javier Bueno,Andreu Llorente,Ramon Guardia,Mar Tormo,Pio Torres,Josep F. Nomdedéu,Emili Montserrat,Jordi Sierra,for CETLAM
Overexpression of survivin in primary ATL cells and sodium arsenite induces apoptosis by down-regulating survivin expression in ATL cell lines
Xiao-Fang Che,Chun-Lei Zheng,Satsuki Owatari,Masato Mutoh,Takenari Gotanda,Hei-Cheul Jeung,Tatsuhiko Furukawa,Ryuji Ikeda,Masatatsu Yamamoto,Misako Haraguchi,Naomichi Arima,Shin-ichi Akiyama
PHAGOCYTES
TRANSPLANTATION
Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer
Elisabeth H. Slager,M. Willy Honders,Edith D. van der Meijden,Simone A. P. van Luxemburg-Heijs,Freke M. Kloosterboer,Michel G. D. Kester,Inge Jedema,W. A. Erik Marijt,M. Ron Schaafsma,Roel Willemze,J. H. Frederik Falkenburg
Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research
Clinical Trials & Observations
Mary Eapen,Elizabeth Raetz,Mei-Jie Zhang,Catherine Muehlenbein,Meenakshi Devidas,Thomas Abshire,Amy Billett,Alan Homans,Bruce Camitta,William L. Carroll,Stella M. Davies,for the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research
CORRESPONDENCE
Linkage and mutational analysis of the CDAN1 gene reveals genetic heterogeneity in congenital dyserythropoietic anemia type I
Momin R. Ahmed,Aref Chehal,Laila Zahed,Ali Taher,Joud Haidar,Ali Shamseddine,Anne-Marie O'Hea,Nicola Bienz,Orly Dgany,Nili Avidan,Jacqui S. Beckmann,Hannah Tamary,Douglas Higgs,Paresh Vyas,William G. Wood,Sunitha N. Wickramasinghe
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement
Email alerts
Advertisement